House bill HR7035-117

Energy and Commerce Committee

Biologics Market Transparency Act of 2022

• Last activity on Mar 10, 2022

• Introduced Mar 09, 2022

• By Rep. Manning, Kathy E. [D-NC-6]

Support this bill

Biologics Market Transparency Act of 2022

This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.

HR7667-117, S4348-117, S4302-117,

Committee
Mar. 10 2022	Referred to the Subcommittee on Health.

IntroReferral
Mar. 09 2022	Referred to the House Committee on Energy and Commerce.

IntroReferral
Mar. 09 2022	Introduced in House Introduced in House